Both groups reported significant increases in their level of sadness (AD: t 16=10.32, P<0.001; healthy comparisons: t 16=12.88, P<0.001) immediately after watching the sad film clips, indicating that the sadness induction was effective (Figure 2). The 2 groups reported similar levels of sadness and negative affect. The groups did not differ significantly in their sadness VAS ratings and negative affect after the induction (F 1,32=2.40; F 1,32=3.42), after the memory test (F 1,32=0.01; F 1,32=0.88), or in the final rating (F 1,32=0.86; F 1,32=0.63).
After the memory test, the AD group reported significantly more positive affect than the healthy comparison group (F 1,32=4.43, P<0.05). There was no significant between-group difference in positive affect after the induction (F 1,32=1.42) or in the final rating (F 1,32=0.31). Table 5 shows more detail about the emotion ratings.
In strong support of our hypothesis, the patients with AD reported feeling elevated levels of sadness that lasted for up to 30 minutes after the films, despite having little or no recollection of the content (Figure 3). The AD group’s mean change in sadness from baseline to immediately after the induction was 65.29; after the memory test, 35.88; and in the final rating, 28.53. Across all participants, the correlation between memory performance and sadness during the final rating was significant, but in a negative direction (r=−0.37, n=34, P<0.05). This paradoxical effect actually suggests that the less the patients remembered about the films, the longer their sadness lasted.
The dissociation between lingering feelings and impaired declarative memory was especially compelling in 4 patients with AD who could not recollect any details about the films. Despite their severe memory impairment, all 4 patients reported sustained feelings of sadness after the memory test, and 3 reported feeling sad even at the final rating 30 minutes post-induction (Figure 4).
We found no significant between-group differences in Inventory of Depression and Anxiety Symptoms scores (t 16=1.16), sadness VAS at baseline (t 16=0.23), or negative affect at baseline (t 16=2.17). To explore further the influence of depressive symptoms on the experience and sustainability of sadness, we conducted a 2×2 (time × group) multivariate analysis of covariance. We used the last 2 emotion measures, “after memory test” and “final rating,” as dependent variables, because these measures reflected sustained feelings of sadness, and we used scores on the Inventory of Depression and Anxiety Symptoms as the covariate. The analysis was not significant (F 2,30=0.99, P=0.38). These results suggest that individual differences in depressive symptoms in our participants were not significantly related to their sustained experience of sadness.
The AD group retained significantly less information about the happy films than did the healthy comparison group (t 16=11.17, P<0.001) (Figure 1). Five patients with AD were unable to recall any factual details about the happy films. The AD group also performed significantly worse than the healthy comparison group on both verbal recognition (t 16=4.91, P<0.001) and picture recognition (t 16=3.17, P<0.01) (Table 4).
We found a significant increase in level of happiness in both the patients with AD (t 16=3.41, P<0.01) and the healthy comparison participants (t 16=5.51, P<0.001) immediately after they watched the film clips (Figure 5). The baseline happiness VAS ratings did not differ significantly between groups (t 16=1.61).
There were no significant between-group differences in happiness ratings obtained after the induction (F 1,32=0.12), after the memory test (F 1,32=0.04), or in the final rating (F 1,32=0.00). Moreover, the groups did not differ significantly in their negative or positive affect ratings obtained after the induction (negative: F 1,31=0.68; positive: F 1,31=2.26), after the memory test (F 1,31=0.40; F 1,31=0.39), or at the final rating (F 1,31=0.90; F 1,32=0.87). Table 6 lists more detailed information about the emotion ratings.
Similar to what we found with the sadness induction, 3 patients with AD had no recall at all for the happy films but continued to experience happiness beyond the memory test, and 2 of them showed elevations in happiness that persisted 30 minutes after the end of the films (Figure 6). This finding further illustrates the dissociation between impaired declarative memory and sustained feelings. We found no significant relationship between memory performance and ratings of happiness during the final rating (r=0.06, n=34).
We found that patients with AD reported feeling sustained states of happiness and sadness despite their impaired declarative memory for the events that had originally triggered the emotional state. Our findings are consistent with previous studies showing that individuals with AD have relatively preserved emotion (Blessing et al, 2006, 2012; Evans-Roberts and Turnbull, 2011). However, our study goes beyond assessing the implicit learning of emotional information and demonstrates that patients with AD are profoundly impacted emotionally by events that they cannot recall. In other words, their feelings persist long after the memories have vanished. Thus, patients with AD exhibit the same phenomenon of “feelings without memory” that we had observed in patients with hippocampal amnesia (Feinstein et al, 2010).
The patients with AD also showed another pattern similar to the patients with hippocampal amnesia: Those patients who had the worst memory for the sad films tended to experience the most prolonged states of sadness (Figures 3 and 4). This counterintuitive finding suggests that a free-floating state of negative emotion, untethered from the original emotion-inducing memory, might be particularly difficult to manage.
This difficulty may stem from the adaptive value of knowing the cause of our negative emotions, which in turn can help expedite our recovery from them. A free-floating state of emotion, especially a negative emotion, triggers a search process aimed at discovering the source of the emotional disturbance (Feinstein, 2013). Unfortunately, the amnesia in patients with AD prevents them from being able to make any conclusive discovery. Their inability to attribute the source of the aberrant emotional state draws further attention to it, in effect creating a positive feedback loop that hijacks the natural recovery process and ultimately leads to an abnormally prolonged state of emotion.
For example, near the end of the post-induction period in this study, a patient with AD who had no recollection for any of the sad films stated, “I feel like all my emotions and feelings are rushing in on me. It’s extremely confusing and I do not like that feeling.” The persistence of this patient’s intense negative emotion and her inability to conjure up a logical explanation for the cause of her feelings illustrate the bewilderment that a patient with AD may experience in the face of an apparently inexplicable feeling.
Other patients reported remembering that something sad had happened but could not recall details about the source of their sadness. One patient said, “They showed so much heartache. I don’t recall seeing joy, just pain and heartache”; again, she could not provide any details. Her reaction echoes research showing that patients with AD may have “source amnesia,” ie, they can recall information but not where, how, or under what circumstances they learned it (Dalla Barba et al, 1999).
Our findings support the idea that the neural systems underlying emotional processing and feeling may be relatively preserved in individuals with AD, especially during the early stages. Previous research has shown that amygdala volumes are positively associated with emotional memory (Adolphs et al, 1997; Cahill et al, 1995; Hamann et al, 1997; Mori et al, 1999). Thus, it is possible that our study patients with AD who sustained the induced emotion may have relatively preserved amygdala function. Understanding the neuroanatomic underpinnings of the ability to sustain an emotion deserves further research, and our laboratory is currently working on this topic.
Our study had several limitations. First, our sample size was only moderate. However, both our individual cases and group means demonstrated that patients with AD can experience feelings for an extended period of time despite impaired declarative memory for what caused the feelings.
Second, our data on feelings were derived from self-report. It could be argued that patients with AD might have difficulty comprehending the questions and identifying their feelings (Sturm and Levenson, 2011). However, several points argue against this as a major explanation of our findings. First, before accepting the patients with AD into the study, we carefully tested them with neuropsychological measures to ensure that they had adequate comprehension to perform the study procedures. Second, the AD group and the healthy comparison group reported similar intensities of induced sadness or happiness, and both groups reported a concomitant decrease in positive affect when their negative affect increased after the sadness induction (Figure 2B), suggesting that the patients were rating their feelings reliably and validly. Third, while watching the films, the patients displayed emotional behaviors, such as crying or laughing, that were consistent with the feelings that they later reported. Previous studies looking at emotional reactivity in patients with AD have also shown preserved facial responses to emotional film clips (Mograbi et al, 2012; Smith, 1995).
A final limitation of our study was that the happy films were not as effective as the sad films at inducing strong emotions. This pattern is in keeping with a common trend in the literature. Inducing happiness in the laboratory is challenging, and negative emotions are generally reported to be more salient than positive emotions (Gerrards-Hesse et al, 1994; Monteil and Francois, 1998). One possible explanation for the difficulty of inducing happiness in the laboratory is that participants tend to report high levels of happiness at baseline (Gerrards-Hesse et al, 1994; Monteil and Francois, 1998). This explanation is consistent with our findings.
Our study highlights the fact that actions toward patients with AD have consequences, even when the patients do not appear to remember the actions. In fact, actions may have a lasting impact on how the patients feel. Older adults in nursing homes and patients with AD can be victims of both verbal and physical mistreatment by staff or caregivers (Schiamberg et al, 2012; VandeWeerd et al, 2006, 2013). Such mistreatment may explain in part the increases in psychiatric symptoms and feelings of loneliness seen in people who have moved into a nursing home (Karakaya et al, 2009; Scocco et al, 2006).
Our findings suggest that even though patients with AD may not remember instances of maltreatment, they can still experience the negative emotions triggered by such events. The fact that these patients’ feelings can persist, even in the absence of memory, highlights the need to avoid causing negative feelings and to try to induce positive feelings with frequent visits and social interactions, exercise, music, dance, jokes, and serving patients their favorite foods. Thus, our findings should empower caregivers by showing them that their actions toward patients really do matter and can significantly influence a patient’s quality of life and subjective well-being.
The fact that forgotten events can continue to exert a profound influence on a patient’s emotional life should be applied to the standard of care in nursing homes and assisted living facilities, and implemented by all caregivers. Jade Angelica (2013) has proposed that caregivers should not try to make patients conform to our version of “reality” because such efforts can leave patients feeling upset and confused. Instead, caregivers should try to view reality from the patient’s perspective and approach the patient with empathy. By adopting an attitude of acceptance and giving patients constant reassurance and positive affirmation, caregivers can potentially induce prolonged states of positive emotion while minimizing negative emotion and instances of noncompliant and aggressive behavior. Similarly, because positive feelings can persist, caregivers should be encouraged to continue interventions such as social dancing (Palo-Bengtsson and Ekman, 2002) and therapeutic games (Cohen et al, 2009).
Despite the considerable amount of research aimed at developing disease-modifying pharmacotherapies for AD, no drug has succeeded at either preventing or substantially influencing the disease’s progression. Against this foreboding backdrop, we would like to suggest that more resources be devoted to the research and dissemination of caregiving techniques that could improve the well-being and minimize the suffering for the millions of individuals afflicted with AD (Angelica, 2013; Edvardsson et al, 2012; Thies et al, 2013). Such a paradigm shift will become even more imperative as the population continues to age and the number of patients with AD rises to epidemic proportions.
The authors thank Karen Peralta, Ganna Savranska, Samantha Korns, and Emily Eilers for help with data collection and management; Jade Angelica for valuable comments; the staff at the Benton Neuropsychology Laboratory and the Alzheimer’s Association for assisting with recruitment; Oliver Turnbull and Daniel Mograbi for their perceptive reviews; and Don Fowles for his insightful comment that became the catalyst for this line of inquiry.
Adolphs R, Cahill L, Schul R, et al.. 1997. Impaired declarative memory for emotional material following bilateral amygdala damage in humans. Learn Mem. 4:291–300.
Angelica JC. 2013. Where Two Worlds Touch: A Spiritual Journey Through Alzheimer’s Disease. Boston, Massachusetts: Skinner House Books.
Blessing A, Keil A, Gruss LF, et al.. 2012. Affective learning and psychophysiological reactivity in dementia patients. Int J Alzheimers Dis. 2012:1–9.
Blessing A, Keil A, Linden DE, et al.. 2006. Acquisition of affective dispositions in dementia patients. Neuropsychologia. 44:2366–2373.
Broster LS, Blonder LX, Jiang Y. 2012. Does emotional memory enhancement assist the memory-impaired? Front Aging Neurosci. 4:1–6.
Bucks RS, Radford SA. 2004. Emotion processing in Alzheimer’s disease. Aging Ment Health. 8:222–232.
Cahill L, Babinsky R, Markowitsch HJ, et al.. 1995. The amygdala and emotional memory. Nature. 377:295–296.
Cohen GD, Firth FM, Biddle S, et al.. 2009. The first therapeutic game specifically designed and evaluated for Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 23:540–551.
Cohen P, Cohen J, Aiken L, et al.. 1999. The problem of units and the circumstance for POMP. Multivar Behav Res. 34:315–346.
Dalla Barba G, Nedjam Z, Dubois B. 1999. Confabulation, executive functions, and source memory in Alzheimer’s disease. Cogn Neuropsychol. 16:385–398.
DeRenzo EG, Conley RR, Love RC. 1998. Assessment of capacity to give consent to research participation: state-of-the-art and beyond. J Health Care Law Policy. 1:66–87.
Edvardsson D, Sandman PO, Rasmussen B. 2012. Forecasting the ward climate: a study from a dementia care unit. J Clin Nurs. 21:1136–1144.
Evans-Roberts CE, Turnbull OH. Remembering relationships: preerved emotion-based learning in Alzheimer’s disease. 2011. Exp Aging Res. 37:1–16.
Feinstein JS. 2013. Lesion studies of human emotion and feeling. Curr Opin Neurobiol. 23:304–309.
Feinstein JS, Duff MC, Tranel D. 2010. Sustained experience of emotion after loss of memory in patients with amnesia. Proc Natl Acad Sci USA. 107:7674–7679.
Fleming K, Kim SH, Doo M, et al.. 2003. Memory for emotional stimuli in patients with Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 18:340–342.
Fox NC, Crum WR, Scahill RI, et al.. 2001. Imaging of onset and progression of Alzheimer’s disease with voxel-compression mapping of serial magnetic resonance images. Lancet. 358:201–205.
Gerrards-Hesse A, Spies K, Hesse FW. 1994. Experimental inductions of emotional states and their effectiveness: a review. Br J Psychol. 85:55–78.
Goodglass H, Kaplan E, Barresi B. 2000. The Boston Diagnostic Aphasia Examination (BDAE-3). 3rd ed.San Antonio, Texas: Pearson.
Gross JJ, Levenson RW. 1995. Emotion elicitation using films. Cogn Emotion. 9:87–108.
Hamann SB, Cahill L, McGaugh JL, et al.. 1997. Intact enhancement of declarative memory for emotional material in amnesia. Learn Mem. 4:301–309.
Hamann SB, Monarch ES, Goldstein FC. 2000. Memory enhancement for emotional stimuli is impaired in early Alzheimer’s disease. Neuropsychology. 14:82–92.
Hyman BT, Van Hoesen GW, Damasio AR, et al.. 1984. Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation. Science. 225:1168–1170.
Hyman BT, Van Hoesen GW, Damasio AR. 1990. Memory-related neural systems in Alzheimer’s disease: an anatomic study. Neurology. 40:1721–1730.
Jack CR Jr, Petersen RC, Xu YC, et al.. 1997. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology. 49:786–794.
Karakaya MG, Bilgin SÇ, Ekici G, et al.. 2009. Functional mobility, depressive symptoms, level of independence, and quality of life of the elderly living at home and in the nursing home. J Am Med Dir Assoc. 10:662–666.
Kazui H, Mori E, Hashimoto M, et al.. 2000. Impact of emotion on memory: controlled study of the influence of emotionally charged material on declarative memory in Alzheimer’s disease. Br J Psychiatry. 177:343–347.
Kensinger EA, Brierly B, Medford N, et al.. 2002. Effects of normal aging and Alzheimer’s disease on emotional memory. Emotion. 2:118–134.
Magai C, Cohen C, Gomberg D, et al.. 1996. Emotional expression during mid- to late-stage dementia. Int Psychogeriatr. 8:383–395.
McKhann GM, Knopman DS, Chertkow H, et al.. 2011. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7:263–269.
Mickes L, Wixted JT, Fennema-Notestine C, et al.. 2007. Progressive impairment on neuropsychological tasks in a longitudinal study of preclinical Alzheimer’s disease. Neuropsychology. 21:696–705.
Moayeri SE, Cahill L, Jin Y, et al.. 2000. Relative sparing of emotionally influenced memory in Alzheimer’s disease. NeuroReport. 11:653–655.
Mograbi DC, Brown RG, Morris RG. 2012. Emotional reactivity to film material in Alzheimer’s disease. Dement Geriatr Cogn Disord. 34:351–359.
Monteil JM, Francois S. 1998. Asymmetry and time span of experimentally induced mood. Curr Psychol Cogn. 17:621–633.
Mori E, Ikeda M, Hirono N, et al.. 1999. Amygdalar volume and emotional memory in Alzheimer’s disease. Am J Psychiatry. 156:216–222.
Morris JC. 1993. The Clinical Dementia Rating (CDR): current vision and scoring rules. Neurology. 43:2412–2414.
Narme P, Mouras H, Roussel M, et al.. 2013. Assessment of socioemotional processes facilitates the distinction between frontotemporal lobar degeneration and Alzheimer’s disease. J Clin Exp Neuropsychol. 35:728–744.
Nashiro K, Mather M. 2011. Effects of emotional arousal on memory binding in normal aging and Alzheimer’s disease. Am J Psychol. 124:301–312.
Palo-Bengtsson L, Ekman S. 2002. Emotional response to social dancing and walks in persons with dementia. Am J Alzheimers Dis Other Demen. 17:149–153.
Philippot P. 1993. Inducing and assessing differentiated emotion-feeling states in the laboratory. Cogn Emotion. 7:171–193.
Reitan RM. 1958. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills. 8:271–276.
Rottenberg J, Ray R, Gross JCoan JA, Allen JJ. 2007. Emotion elicitation using films. Handbook of Emotion Elicitation and Assessment. New York, New York: Oxford University Press;9–28.
Sabat SR, Collins M. 1999. Intact social, cognitive ability, and selfhood: a case study of Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 14:11–19.
Schaefer A, Nils F, Sanchez X, et al.. 2010. Assessing the effectiveness of a large database of emotion-eliciting films: a new tool for emotion researchers. Cogn Emot. 24:1153–1172.
Schiamberg LB, Oehmke J, Zhang Z, et al.. 2012. Physical abuse of older adults in nursing homes: a random sample survey of adults with an elderly family member in a nursing home. J Elder Abuse Negl. 24:65–83.
Schmidt M. 1996.Rey Auditory and Verbal Learning Test: A Handbook. Los Angeles, California: Western Psychological Services.
Scocco P, Rapattoni M, Fantoni G. 2006. Nursing home institutionalization: a source of eustress or distress for the elderly? Int J Geriatr Psychiatry. 24:281–287.
Smith MC. 1995. Facial expression in mild dementia of the Alzheimer type. Behav Neurol. 8:149–156.
Spielberger CD, Gorsuch RL, Lushene R, et al.. 1983. Manual for the State-Trait Anxiety Inventory. Palo Alto, California: Consulting Psychologists Press.
Sturm VE, Levenson RW. 2011. Alexithymia in neurodegenerative disease. Neurocase. 17:242–250.
Thies W, Bleiler L. Alzheimer’s Association. 2013. Alzheimer’s Association facts and figures. Alzheimers Dement. 9:208–245.
VandeWeerd C, Paveza GJ. 2006. Verbal mistreatment in older adults: a look at persons with Alzheimer’s disease and their caregivers in the state of Florida. J Elder Abuse Negl. 17:11–30.
VandeWeerd C, Paveza GJ, Walsh M, et al.. 2013. Physical mistreatment in persons with Alzheimer’s disease. J Aging Res. 2013:1–10.
Watson D, O’Hara MW, Chmielewski M, et al.. 2008. Further validation of the IDAS: evidence of convergent, discriminant, criterion, and incremental validity. Psychol Assess. 20:248–259.
Wechsler D. 2008. WAIS-IV Administration and Scoring Manual. San Antonio, Texas: The Psychological Corporation.
Keywords:© 2014 by Lippincott Williams & Wilkins.
amnesia; emotion; aging; declarative memory; emotional memory